Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,92 SEK | -7,02% | +2,67% | +8,35% |
Omzet 2021 | 844K 77,59K 72,71K | Omzet 2022 | 1,14 mln. 105K 98,64K | Marktkapitalisatie | 595 mln. 54,72 mln. 51,28 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -156 mln. -14,34 mln. -13,44 mln. | Nettowinst (verlies) 2022 | -168 mln. -15,45 mln. -14,47 mln. | EV/omzet 2021 | 1.710 x |
Nettoliquiditeiten 2021 | 254 mln. 23,37 mln. 21,89 mln. | Nettoliquiditeiten 2022 | 68,47 mln. 6,29 mln. 5,9 mln. | EV/omzet 2022 | 460 x |
K/w-verhouding 2021 |
-10,9
x | K/w-verhouding 2022 |
-3,54
x | Werknemers | 11 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 75,34% |
Recentste transcriptie over Immunovia AB
1 dag | -7,02% | ||
1 week | +2,67% | ||
Lopende maand | +40,35% | ||
1 maand | +42,22% | ||
3 maanden | +7,14% | ||
6 maanden | +225,98% | ||
Lopend jaar | +8,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 01-04-22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 01-03-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 09-12-16 | |
Peter Andersen
CHM | Chairman | 67 | 01-01-20 |
Michael Löfman
BRD | Director/Board Member | - | 22-05-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 1,92 | -7,02% | 914 521 |
22-04-24 | 2,065 | +17,73% | 3 201 853 |
19-04-24 | 1,754 | -1,90% | 233 227 |
18-04-24 | 1,788 | +1,94% | 109 354 |
17-04-24 | 1,754 | -6,20% | 158 116 |
uitgestelde koers Nasdaq Stockholm, 23 april 2024 om 15:24 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+8,35% | 8,57 mln. | |
-11,58% | 18,01 mld. | |
-46,53% | 2,61 mld. | |
+11,47% | 1,76 mld. | |
-9,12% | 1,51 mld. | |
+21,84% | 1,17 mld. | |
-17,88% | 943 mln. | |
-22,88% | 883 mln. | |
-6,77% | 701 mln. | |
-16,78% | 693 mln. |